Precision Medicine: Decoding Your Cancer

September 29, 2018

Breast cancer treatment today is no longer one-size-fits all. This approach—often called precision medicine—uses genomic tests to determine what drives the cancer’s growth and which treatments are most likely to halt it. In this keynote, Dr. Kathy Miller discussed the impact of genomic tests in treating breast cancers of all stages, how researchers use these tests and explored the cutting-edge medicines available now, often through clinical trials, based on information gathered from them.